• Explore /
  • Poster
  • / Comparison of TAS0953/HM06 and selpercatinib in <em>RET </em>fusion-driven preclinical disease models of intracranial metastases.

Comparison of TAS0953/HM06 and selpercatinib in RET fusion-driven preclinical disease models of intracranial metastases.

Abstract Poster

Authors

null

Igor Odintsov

Brigham and Women's Hospital, Boston, MA

Igor Odintsov , Allan J.W. Lui , Kota Ishizawa , Isao Miyazaki , Inna Khodos , Kentaro Wakayama , Morana Vojnic , Connor J. Hagen , Qing Chang , Annalisa Bonifacio , Claudio Giuliano , Elisa de Stanchina , Emanuela Lovati , Emily Cheng , Marc Ladanyi , Romel Somwar

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Central Nervous System Tumors

Track

Central Nervous System Tumors

Sub Track

Brain Metastases

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 2024)

DOI

10.1200/JCO.2022.40.16_suppl.2024

Abstract #

2024

Poster Bd #

362

Abstract Disclosures

Similar Posters

First Author: Theresa Bayt

First Author: Yonina R. Murciano-Goroff

First Author: Leeseul Kim

First Author: Makoto Nishio